Cited by

• Chlorimipramine, electroconvulsive shock and combination thereof: differential effects of chronic treatment on apomorphine-induced behaviours and on striatal and mesocortical dopamine turnover.

  Spyraki C, Papadopoulou Z, Kourkoubas A, Varonos D. Spyraki C, et al. Naunyn Schmiedebergs Arch Pharmacol. 1985 Apr;329(2):128-34. doi: 10.1007/BF00501201. Naunyn Schmiedebergs Arch Pharmacol. 1985. PMID: 4040217
• Evaluation of the levels of free and total amitriptyline and metabolites in the plasma and brain of the rat after long-term administration of doses used in receptor studies.

  Baumann P, Gaillard JM, Jonzier-Perey M, Gerber C, Bouras C. Baumann P, et al. Psychopharmacology (Berl). 1984;84(4):489-95. doi: 10.1007/BF00431455. Psychopharmacology (Berl). 1984. PMID: 6441950
• Electroconvulsive treatment and haloperidol: effects on pre- and postsynaptic dopamine receptors in rat brain.

  Reches A, Wagner HR, Barkai AI, Jackson V, Yablonskaya-Alter E, Fahn S. Reches A, et al. Psychopharmacology (Berl). 1984;83(2):155-8. doi: 10.1007/BF00429725. Psychopharmacology (Berl). 1984. PMID: 6431465
• Long-term administration of m-chlorophenylpiperazine (mCPP) to rats induces changes in serotonin receptor binding, dopamine levels and locomotor activity without altering prolactin and corticosterone secretion.

  Ulrichsen J, Partilla JS, Dax EM. Ulrichsen J, et al. Psychopharmacology (Berl). 1992;107(2-3):229-35. doi: 10.1007/BF02245142. Psychopharmacology (Berl). 1992. PMID: 1352053
• Double-blind, placebo-controlled, hormonal, syndromal and EEG mapping studies with transdermal oestradiol therapy in menopausal depression.

  Saletu B, Brandstätter N, Metka M, Stamenkovic M, Anderer P, Semlitsch HV, Heytmanek G, Huber J, Grünberger J, Linzmayer L, et al. Saletu B, et al. Psychopharmacology (Berl). 1995 Dec;122(4):321-9. doi: 10.1007/BF02246261. Psychopharmacology (Berl). 1995. PMID: 8657828 Clinical Trial.